Expertise in
18
conditions

Dr. Kris V. Kowdley

Hepatology
Office
1124 Columbia St Ste 600, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
36 Years of Experience
Expertise in
18
conditions
Office
1124 Columbia St Ste 600, 
Seattle, WA 

Overview

Kris Kowdley is a Hepatologist practicing medicine in Seattle, Washington. He has been practicing medicine for over 36 years.

Dr. Kowdley is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Primary Biliary Cholangitis, Cholangitis, Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, and Liver Transplant.

He is actively involved in clinical research, co-authoring 304 peer reviewed articles and participating in 19 clinical trials. Dr. Kowdley is currently accepting new patients.

Specialties

Hepatology

Licenses

Internal Medicine in WA

Languages Spoken

English
Tamil

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Office
1124 Columbia St Ste 600, Seattle, WA 98104

Additional Areas of Focus

Dr. Kowdley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

19 Clinical Trials

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
Enrollment Status: Completed
Publish Date: August 25, 2026
Intervention Type: Drug
Study Drug: HTD1801 (BUDCA)
Study Phase: Phase 2
A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adult Subjects With Primary Sclerosing Cholangitis (PSC)
A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adult Subjects With Primary Sclerosing Cholangitis (PSC)
Enrollment Status: Completed
Publish Date: August 25, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Completed
Publish Date: August 19, 2026
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: June 22, 2026
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Drug
Study Drug: Vitamin E
Study Phase: Phase 2
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Enrollment Status: Terminated
Publish Date: September 17, 2025
Intervention Type: Other
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Enrollment Status: Completed
Publish Date: August 13, 2025
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
View 9 Less Clinical Trials

304 Total Publications

Burden of fatigue or pruritus in patients with primary biliary cholangitis: a United States matched case-control study.
Burden of fatigue or pruritus in patients with primary biliary cholangitis: a United States matched case-control study.
Journal: Journal of comparative effectiveness research
Published: August 12, 2026
Similar Doctors
Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Kaiser Permanente Specialty Center Gastroenterology

125 16th Avenue East, Suite CSB-2, 
Seattle, WA 
 (2.9 miles away)
206-326-3050
Languages Spoken:
English
See accepted insurances

Charles Landis is a Hepatologist practicing medicine in Seattle, Washington. Dr. Landis is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Sclerosing Cholangitis, Cholangitis, and Liver Transplant.

Expertise in
23
conditions
Dr. Asma Siddique
Hepatology | Gastroenterology
Expertise in
23
conditions
Dr. Asma Siddique
Hepatology | Gastroenterology
Referral may be required
Before you request

Virginia Mason Medical Center

1100 Ninth Avenue, 
Seattle, WA 
 (0.5 miles away)
206-223-2319
Languages Spoken:
English, Russian, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Asma Siddique, MD, is a fellowship-trained hepatologist with special medical interest in all liver diseases, including metabolic liver disease, genetic liver disease, fatty liver disease, cholestatic liver disease, hepatitis B and C, liver cancer, primary biliary cirrhosis and primary sclerosing cholangitis. In addition to her clinical practice, she also participates in clinical research with a focus on hepatitis C.Dr. Siddique enjoys getting to know her patients, creating a strong connection and working to help them feel better. For her liver cancer patients, who require very individualized treatment, she takes a team approach, involving an oncologist, surgeon and interventional radiologist in addition to herself as the hepatologist.Dr. Siddique enjoys reading, skiing, traveling and spending time with her daughter. Dr. Siddique is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Hepatitis, Cirrhosis, and Tissue Biopsy. Dr. Siddique is board certified in American Board Of Internal Medicine. Dr. Siddique is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
3216 Ne 45th Pl Ste 212, 
Seattle, WA 
 (4.5 miles away)
206-536-3030
Languages Spoken:
English
See accepted insurances

Aalam Sohal is a Hepatologist practicing medicine in Seattle, Washington. Dr. Sohal is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cholangitis, Non-Alcoholic Fatty Liver Disease, Sclerosing Cholangitis, Liver Transplant, and Endoscopy.

Frequently Asked Questions about Dr. Kris V. Kowdley

How do I make an appointment with Dr. Kris V. Kowdley?

You can book an appointment with Dr. Kris V. Kowdley by calling their office at 206-386-3660. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kris V. Kowdley a top-rated expert for Primary Biliary Cholangitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kris V. Kowdley is classified as an Elite expert for Primary Biliary Cholangitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kris V. Kowdley specialize in?

While Dr. Kris V. Kowdley is a Hepatology, they have specific expertise in Primary Biliary Cholangitis, Cholangitis, and Nonalcoholic Steatohepatitis (NASH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hepatology.

Does Dr. Kris V. Kowdley participate in research or clinical trials?

Yes. Dr. Kris V. Kowdley has published 304 articles and abstracts on conditions like Primary Biliary Cholangitis. You can view a list of Dr. Kris V. Kowdley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kris V. Kowdley accept my insurance?

Dr. Kris V. Kowdley accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 206-386-3660 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kowdley's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 9 Advanced Conditions
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile